2021
|
|

Abstract: Background Convalescent plasma is undergoing randomized trials as a potential therapeutic option for COVID‐19 infection. Little empirical evidence exists regarding the determination of donor eligibility and experiences with donor selection. Study Design and Methods This prospective study was conducted at a tertiary care hospital in New York to select plasma donors for a randomized, double‐blind, controlled convalescent plasma trial. Clearance for donation required succe… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
4
0

Publication Types

Select...

Relationship

0
0

Authors

Journals